Department of Surgery, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany; Department of Gastroenterology and Hepatology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
Department of General, Visceral and Transplant Surgery, University Hospital Aachen, Rhine-Westphalia Institute of Technology, Pauwelsstraße 30, 52074 Aachen, Germany.
Int J Surg. 2019 Nov;71:56-65. doi: 10.1016/j.ijsu.2019.08.033. Epub 2019 Sep 5.
Hepatocellular carcinoma is the fifth most prevalent cancer worldwide. High tumour recurrence is the most common cause of the impaired 5-year survival rate of 26-58% after hepatectomy. The aim of this study was to investigate the impact of preoperative dynamic liver function on long-term outcome.
A total of 146 patients that underwent curative resection for HCC at our department from 2005 to 2016 were analysed. Univariate analysis was calculated using Kaplan-Meier method. Multivariable analysis was carried out with Cox regression.
The cumulative 1-, 3-, 5-year survival rates were 83%, 42% and 14%, respectively. Multivariable Cox regression yielded that overall survival depends on disease recurrence, haemoglobin, number of tumours, liver cirrhosis, lymphatic vessel invasion, UICC stage and postoperative complications. The corresponding 1-, 3-, 5-year disease-free survival rates were 73%, 32% and 10%, respectively. Multivariable analysis yielded preoperative liver function capacity (HR 2.421; p = 0.014), vascular invasion (HR 2.116; p = 0.034) and UICC stage (HR 2.200; p = 0.037) as risk factors associated with disease-free survival. A subanalysis with respect to the degree of functional impairment implicated that severity of liver function impairment is correlated with the disease-free survival rate.
This study shows that preoperative dynamic liver function assessed by LiMAx test as well as severity of underlying liver disease have a significant impact on recurrence-free survival after curative hepatectomy. Patients presenting with impaired liver function should be evaluated for other treatment e.g. liver transplantation or receive closer oncological follow-up.
肝细胞癌是全球第五大常见癌症。高肿瘤复发率是影响手术后 5 年存活率(26-58%)的最常见原因。本研究旨在探讨术前动态肝功能对长期预后的影响。
对 2005 年至 2016 年期间在我科接受根治性肝切除术的 146 例 HCC 患者进行分析。使用 Kaplan-Meier 方法进行单因素分析。采用 Cox 回归进行多因素分析。
累积 1、3、5 年生存率分别为 83%、42%和 14%。多因素 Cox 回归显示,总生存取决于疾病复发、血红蛋白、肿瘤数量、肝硬化、淋巴管侵犯、UICC 分期和术后并发症。相应的 1、3、5 年无病生存率分别为 73%、32%和 10%。多因素分析得出术前肝功能(HR 2.421;p=0.014)、血管侵犯(HR 2.116;p=0.034)和 UICC 分期(HR 2.200;p=0.037)是与无病生存相关的危险因素。关于肝功能损伤程度的亚分析表明,肝功能损伤的严重程度与无病生存率相关。
本研究表明,LiMAx 试验评估的术前动态肝功能以及基础肝病的严重程度对根治性肝切除术后无复发生存率有显著影响。肝功能受损的患者应评估其他治疗方法,例如肝移植或接受更密切的肿瘤随访。